Marjorie Wallace, one of the UK’s leading mental health campaigners, was honoured last week at the Communiqué Awards 2014. Wallace, who founded the charity SANE, was named Healthcare Communications ...

The US government has announced the ten drugs selected for the first round of pricing negotiations under President Biden’s Inflation Reduction Act (IRA). The IRA allows Medicare, the government health ...

German biotech company CureVac is planning to expand the protocols for its ongoing late-stage trials of its COVID-19 vaccine candidate CVnCoV to determine if the jab is effective against new virus ...

Ipsen’s cabozantinib has been recommended by the National Institute for Health and Care Excellence (NICE) as an option for patients with previously treated advanced hepatocellular carcinoma (HCC).

Novo Nordisk and Echosens, a high-technology company specialising in liver diagnostics, have collaborated to advance early diagnosis of non-alcoholic steatohepatitis (NASH). The partnership aims to ...

The US health department has proposed three new models to help lower the cost of drugs, promote accessibility and improve quality of care for those enrolled in voluntary government health insurance ...

Astellas Pharma and Cullgen have announced a research collaboration and exclusive option agreement aimed at advancing targeted protein degraders, with the deal potentially worth up to $1.9bn. Protein ...

Biogen’s oral multiple sclerosis product Tecfidera has been a massive earner for the company, but is facing challenges to its patents. The company’s now filed a follow-up in the US to try to defend ...

Merck & Co – known as MSD outside the US and Canada – and Moderna have announced positive phase 2b trial results investigating the use of their personalised mRNA cancer vaccine, mRNA-4157/V940, in ...

New national surveillance data announced at the UK Health Security Agency (UKHSA) annual conference has demonstrated an increase in antibiotic resistant infections and associated deaths in England.

Eli Lilly and AbCellera are the latest contenders to join the fight against the novel coronavirus, after announcing they have partnered on the development of antibody therapies targeting the virus.

An estimated 10.6 million were infected with TB in 2021, an increase of 4.5% from 2020 The number of estimated deaths from tuberculosis (TB) increased between 2020 and 2021 as the COVID-19 pandemic ...